Vitamin K Antagonists Versus Direct Oral Anticoagulation After Transcatheter Mitral Valve Replacement

Maja Wichhart Donzo(Emory University Hospital), Patrick Gleason(Emory University), Adam B. Greenbaum(Brigham and Women's Hospital), Nikoloz Shekiladze(Emory University), John Lisko(Emory University Hospital), Hiroki Ueyama(Emory University), Juan Daniel Del Cid Fratti(Emory University Hospital), Elsa Hebbo(Emory University Hospital), Swapnil Garg(Emory University Hospital), Isida Byku(AID Atlanta), Anas Noman(Emory University), Anton Camaj(Columbia University Irving Medical Center), Chandan Devireddy, George Hanzel(Emory University Hospital), Andrew Murphy(Emory University Hospital), Vasilis Babaliaros(Valve (United States)), Joe Xie(Emory University), Arslan Zahid(Emory University Hospital)
The American Journal of Cardiology
July 17, 2025
10.1016/j.amjcard.2025.07.013
Cited by 0

Related Papers

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
|The Lancet|2018|775
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
|The Lancet|2017|734
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
|The Lancet|2020|586
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
|European Heart Journal|2014|540
Characterization of Myocardial Injury in Patients With COVID-19
|Journal of the American College of Cardiology|2020|429